| 0 |
BLOOD HIV RNA FLUCTUATION |
1 |
0.1111 |
| 1 |
INCOMPLETE COURSE OF VACCINATION |
1 |
0.1000 |
| 2 |
FLOPPY EYELID SYNDROME |
3 |
0.0857 |
| 3 |
LISTERAEMIA |
2 |
0.0800 |
| 4 |
PLETHORIC FACE |
2 |
0.0690 |
| 5 |
VIRAL LOAD ABNORMAL |
10 |
0.0571 |
| 6 |
PRIMARY SYPHILIS |
1 |
0.0526 |
| 7 |
LUPUS HEPATITIS |
1 |
0.0417 |
| 8 |
LONG QT SYNDROME CONGENITAL |
3 |
0.0333 |
| 9 |
PSYCHOTHERAPY |
1 |
0.0333 |
| 10 |
CSF HIV ESCAPE SYNDROME |
4 |
0.0290 |
| 11 |
DRUG RESISTANCE MUTATION |
5 |
0.0281 |
| 12 |
CD4 LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0227 |
| 13 |
PROSTATIC DYSPLASIA |
1 |
0.0222 |
| 14 |
JEJUNECTOMY |
1 |
0.0222 |
| 15 |
MESENTERIC PANNICULITIS |
6 |
0.0201 |
| 16 |
INFUSION SITE DRYNESS |
1 |
0.0185 |
| 17 |
HYPERPHOSPHATURIA |
2 |
0.0171 |
| 18 |
HEPATIC ARTERY THROMBOSIS |
5 |
0.0171 |
| 19 |
HYPOZINCAEMIA |
1 |
0.0169 |
| 20 |
PASTEURELLA INFECTION |
2 |
0.0155 |
| 21 |
BLOOD HIV RNA INCREASED |
28 |
0.0154 |
| 22 |
AIDS RELATED COMPLICATION |
1 |
0.0154 |
| 23 |
HIV VIRAEMIA |
3 |
0.0143 |
| 24 |
DISSEMINATED COCCIDIOIDOMYCOSIS |
2 |
0.0142 |
| 25 |
INTERVENTIONAL PROCEDURE |
1 |
0.0135 |
| 26 |
COLD TYPE HAEMOLYTIC ANAEMIA |
3 |
0.0128 |
| 27 |
LATENT AUTOIMMUNE DIABETES IN ADULTS |
2 |
0.0117 |
| 28 |
HYPERAROUSAL |
1 |
0.0116 |
| 29 |
MAXILLOFACIAL OPERATION |
1 |
0.0115 |
| 30 |
COELIAC ARTERY STENOSIS |
1 |
0.0110 |
| 31 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
3 |
0.0108 |
| 32 |
PENILE INFECTION |
2 |
0.0103 |
| 33 |
ANORECTAL POLYP |
1 |
0.0093 |
| 34 |
HIV-ASSOCIATED NEUROCOGNITIVE DISORDER |
1 |
0.0090 |
| 35 |
MUCOSAL INFECTION |
2 |
0.0085 |
| 36 |
CD4 LYMPHOCYTES DECREASED |
18 |
0.0084 |
| 37 |
NECROTIC LYMPHADENOPATHY |
1 |
0.0083 |
| 38 |
CONGENITAL SKIN DIMPLES |
2 |
0.0083 |
| 39 |
MESENTERIC ARTERY STENOSIS |
1 |
0.0082 |
| 40 |
AMYLASE ABNORMAL |
1 |
0.0080 |
| 41 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
8 |
0.0078 |
| 42 |
BONE DEMINERALISATION |
8 |
0.0076 |
| 43 |
HYPERPLASTIC CHOLECYSTOPATHY |
1 |
0.0074 |
| 44 |
PANCREATIC DUCT DILATATION |
2 |
0.0073 |
| 45 |
DUCTAL ADENOCARCINOMA OF PANCREAS |
2 |
0.0072 |
| 46 |
BETA 2 MICROGLOBULIN URINE INCREASED |
1 |
0.0070 |
| 47 |
VIRAL MUTATION IDENTIFIED |
25 |
0.0068 |
| 48 |
PANCREATIC INJURY |
2 |
0.0066 |
| 49 |
VIROLOGIC FAILURE |
34 |
0.0063 |
| 50 |
MYCOBACTERIUM KANSASII INFECTION |
1 |
0.0061 |
| 51 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
2 |
0.0057 |
| 52 |
VISCERAL LEISHMANIASIS |
4 |
0.0055 |
| 53 |
CD4 LYMPHOCYTES ABNORMAL |
1 |
0.0048 |
| 54 |
LIPODYSTROPHY ACQUIRED |
10 |
0.0047 |
| 55 |
PATHOGEN RESISTANCE |
42 |
0.0046 |
| 56 |
PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT |
4 |
0.0046 |
| 57 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0045 |
| 58 |
LIPASE ABNORMAL |
1 |
0.0045 |
| 59 |
HYPERINSULINAEMIC HYPOGLYCAEMIA |
1 |
0.0045 |
| 60 |
HIGH DENSITY LIPOPROTEIN ABNORMAL |
1 |
0.0043 |
| 61 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
20 |
0.0040 |
| 62 |
FACIAL WASTING |
1 |
0.0037 |
| 63 |
BURSITIS INFECTIVE |
2 |
0.0037 |
| 64 |
DEVICE MAINTENANCE ISSUE |
2 |
0.0034 |
| 65 |
EXTRAPULMONARY TUBERCULOSIS |
1 |
0.0034 |
| 66 |
ANOGENITAL WARTS |
3 |
0.0034 |
| 67 |
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT |
1 |
0.0032 |
| 68 |
LIPOHYPERTROPHY |
2 |
0.0032 |
| 69 |
WOUND INFECTION PSEUDOMONAS |
1 |
0.0032 |
| 70 |
GLOMERULOSCLEROSIS |
2 |
0.0032 |
| 71 |
SERUM FERRITIN ABNORMAL |
1 |
0.0031 |
| 72 |
ALLERGY TO ARTHROPOD BITE |
1 |
0.0031 |
| 73 |
EXTRAOCULAR MUSCLE DISORDER |
1 |
0.0031 |
| 74 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 75 |
NEONATAL INFECTION |
1 |
0.0029 |
| 76 |
RECTAL CANCER METASTATIC |
1 |
0.0029 |
| 77 |
ANDROGEN DEFICIENCY |
1 |
0.0028 |
| 78 |
SYPHILIS |
2 |
0.0028 |
| 79 |
EOSINOPHILIC COLITIS |
1 |
0.0027 |
| 80 |
PERFORATED ULCER |
2 |
0.0026 |
| 81 |
DISEASE RISK FACTOR |
1 |
0.0025 |
| 82 |
GLOMERULONEPHRITIS |
6 |
0.0024 |
| 83 |
VIRAL LOAD INCREASED |
9 |
0.0023 |
| 84 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
3 |
0.0023 |
| 85 |
CONGESTIVE HEPATOPATHY |
1 |
0.0022 |
| 86 |
OESOPHAGEAL ADENOCARCINOMA |
1 |
0.0021 |
| 87 |
ANAL CANCER |
2 |
0.0021 |
| 88 |
TOBACCO USER |
3 |
0.0020 |
| 89 |
ULNA FRACTURE |
2 |
0.0020 |
| 90 |
ANHEDONIA |
53 |
0.0020 |
| 91 |
GASTROINTESTINAL TUBE INSERTION |
5 |
0.0020 |
| 92 |
CAROTID ARTERIOSCLEROSIS |
2 |
0.0019 |
| 93 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
1 |
0.0019 |
| 94 |
INFUSION SITE CELLULITIS |
1 |
0.0019 |
| 95 |
COATING IN MOUTH |
1 |
0.0019 |
| 96 |
ALBUMINURIA |
1 |
0.0019 |
| 97 |
METABOLIC SYNDROME |
3 |
0.0018 |
| 98 |
HELICOBACTER TEST POSITIVE |
1 |
0.0018 |
| 99 |
STRESS AT WORK |
2 |
0.0018 |
| 100 |
PROSTATECTOMY |
1 |
0.0017 |
| 101 |
ALOPECIA AREATA |
3 |
0.0017 |
| 102 |
DRUG RESISTANCE |
43 |
0.0017 |
| 103 |
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL |
1 |
0.0017 |
| 104 |
RENAL TUBULAR INJURY |
2 |
0.0016 |
| 105 |
PROTHROMBIN TIME RATIO DECREASED |
1 |
0.0016 |
| 106 |
HEPATITIS B REACTIVATION |
5 |
0.0016 |
| 107 |
DYSLIPIDAEMIA |
8 |
0.0016 |
| 108 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 109 |
ADJUSTMENT DISORDER |
2 |
0.0015 |
| 110 |
MYELOPROLIFERATIVE NEOPLASM |
1 |
0.0015 |
| 111 |
INSULIN RESISTANCE |
3 |
0.0014 |
| 112 |
RENAL TUBULAR DISORDER |
4 |
0.0014 |
| 113 |
LIPIDS ABNORMAL |
1 |
0.0014 |
| 114 |
LIVER TRANSPLANT |
5 |
0.0014 |
| 115 |
DIET REFUSAL |
1 |
0.0014 |
| 116 |
SKIN STRIAE |
2 |
0.0013 |
| 117 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
2 |
0.0013 |
| 118 |
ECONOMIC PROBLEM |
20 |
0.0013 |
| 119 |
DEBRIDEMENT |
1 |
0.0013 |
| 120 |
MULTIPLE-DRUG RESISTANCE |
4 |
0.0013 |
| 121 |
GALLBLADDER POLYP |
1 |
0.0013 |
| 122 |
MITOCHONDRIAL TOXICITY |
1 |
0.0012 |
| 123 |
ALLERGIC SINUSITIS |
1 |
0.0012 |
| 124 |
BLOOD TRIGLYCERIDES ABNORMAL |
1 |
0.0011 |
| 125 |
LUNG OPACITY |
3 |
0.0011 |
| 126 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 127 |
OSTEOPENIA |
17 |
0.0011 |
| 128 |
INJECTION SITE ULCER |
1 |
0.0011 |
| 129 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 130 |
CYTOMEGALOVIRUS CHORIORETINITIS |
2 |
0.0010 |
| 131 |
IDIOSYNCRATIC DRUG REACTION |
1 |
0.0010 |
| 132 |
STRABISMUS |
3 |
0.0010 |
| 133 |
GENE MUTATION |
2 |
0.0010 |
| 134 |
GASTRECTOMY |
1 |
0.0010 |
| 135 |
CACHEXIA |
5 |
0.0010 |
| 136 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 137 |
INFUSION SITE MASS |
1 |
0.0009 |
| 138 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 139 |
HENOCH-SCHONLEIN PURPURA |
2 |
0.0009 |
| 140 |
COCCIDIOIDOMYCOSIS |
1 |
0.0008 |
| 141 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 142 |
GLYCOSYLATED HAEMOGLOBIN ABNORMAL |
1 |
0.0008 |
| 143 |
FEBRILE CONVULSION |
1 |
0.0008 |
| 144 |
LIPOMA |
2 |
0.0008 |
| 145 |
BONE DENSITY DECREASED |
24 |
0.0008 |
| 146 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
2 |
0.0007 |
| 147 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
1 |
0.0007 |
| 148 |
RENAL ARTERY STENOSIS |
1 |
0.0007 |
| 149 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 150 |
VIRAEMIA |
1 |
0.0007 |
| 151 |
HEPATIC CYTOLYSIS |
9 |
0.0007 |
| 152 |
METASTATIC NEOPLASM |
3 |
0.0007 |
| 153 |
HYPERTONIC BLADDER |
2 |
0.0007 |
| 154 |
TREATMENT NONCOMPLIANCE |
37 |
0.0007 |
| 155 |
ODYNOPHAGIA |
4 |
0.0007 |
| 156 |
MENTAL FATIGUE |
1 |
0.0007 |
| 157 |
STEROID DIABETES |
1 |
0.0007 |
| 158 |
SMALL CELL LUNG CANCER |
1 |
0.0007 |
| 159 |
END STAGE RENAL DISEASE |
12 |
0.0007 |
| 160 |
HEPATOCELLULAR CARCINOMA |
5 |
0.0007 |
| 161 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 162 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 163 |
CALCULUS URINARY |
1 |
0.0006 |
| 164 |
OSTEOMALACIA |
1 |
0.0006 |
| 165 |
MYELITIS |
1 |
0.0006 |
| 166 |
GASTROSTOMY |
1 |
0.0006 |
| 167 |
FAMILY STRESS |
2 |
0.0006 |
| 168 |
OSTEOPOROSIS |
26 |
0.0006 |
| 169 |
CHRONIC KIDNEY DISEASE |
48 |
0.0006 |
| 170 |
PROTEINURIA |
12 |
0.0006 |
| 171 |
CUSHINGOID |
2 |
0.0006 |
| 172 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 173 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 174 |
GLIOBLASTOMA |
1 |
0.0006 |
| 175 |
FANCONI SYNDROME ACQUIRED |
1 |
0.0006 |
| 176 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 177 |
EMOTIONAL DISTRESS |
65 |
0.0005 |
| 178 |
LUPUS NEPHRITIS |
1 |
0.0005 |
| 179 |
QUALITY OF LIFE DECREASED |
7 |
0.0005 |
| 180 |
HEPATIC MASS |
1 |
0.0005 |
| 181 |
METABOLIC DISORDER |
3 |
0.0005 |
| 182 |
CONVERSION DISORDER |
1 |
0.0005 |
| 183 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 184 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 185 |
DECREASED INTEREST |
3 |
0.0005 |
| 186 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0005 |
| 187 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 188 |
ARTHRITIS BACTERIAL |
2 |
0.0005 |
| 189 |
CHEST INJURY |
1 |
0.0005 |
| 190 |
SKIN INDURATION |
1 |
0.0005 |
| 191 |
LIVE BIRTH |
4 |
0.0005 |
| 192 |
INFUSION SITE SWELLING |
3 |
0.0005 |
| 193 |
MULTIPLE INJURIES |
3 |
0.0005 |
| 194 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 195 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 196 |
DECREASED ACTIVITY |
5 |
0.0005 |
| 197 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
2 |
0.0005 |
| 198 |
GASTRIC BYPASS |
1 |
0.0005 |
| 199 |
BIPOLAR I DISORDER |
1 |
0.0005 |
| 200 |
FEAR OF DEATH |
1 |
0.0004 |
| 201 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 202 |
BRAIN OPERATION |
1 |
0.0004 |
| 203 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 204 |
ENCEPHALITIS |
3 |
0.0004 |
| 205 |
LARGE INTESTINE POLYP |
3 |
0.0004 |
| 206 |
NEPHROPATHY |
4 |
0.0004 |
| 207 |
MULTIPLE FRACTURES |
7 |
0.0004 |
| 208 |
SARCOIDOSIS |
2 |
0.0004 |
| 209 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 210 |
HUMERUS FRACTURE |
2 |
0.0004 |
| 211 |
LYMPHADENITIS |
1 |
0.0004 |
| 212 |
ACUTE PSYCHOSIS |
1 |
0.0004 |
| 213 |
PROTEIN URINE PRESENT |
2 |
0.0004 |
| 214 |
VENOOCCLUSIVE DISEASE |
1 |
0.0004 |
| 215 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 216 |
EYELID PTOSIS |
4 |
0.0004 |
| 217 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 218 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 219 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 220 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 221 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 222 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 223 |
HYPERLACTACIDAEMIA |
1 |
0.0004 |
| 224 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
3 |
0.0004 |
| 225 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 226 |
PARANOIA |
6 |
0.0003 |
| 227 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 228 |
APATHY |
5 |
0.0003 |
| 229 |
GLUCOSE TOLERANCE IMPAIRED |
2 |
0.0003 |
| 230 |
HIV INFECTION |
1 |
0.0003 |
| 231 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 232 |
IRITIS |
1 |
0.0003 |
| 233 |
DYSAESTHESIA |
1 |
0.0003 |
| 234 |
DUODENITIS |
1 |
0.0003 |
| 235 |
LIVER INJURY |
8 |
0.0003 |
| 236 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 237 |
APPENDICITIS |
3 |
0.0003 |
| 238 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 239 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 240 |
PROCTALGIA |
2 |
0.0003 |
| 241 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
8 |
0.0003 |
| 242 |
INFUSION SITE PAIN |
4 |
0.0003 |
| 243 |
LIVER ABSCESS |
1 |
0.0003 |
| 244 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 245 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 246 |
UVEITIS |
4 |
0.0003 |
| 247 |
WOUND COMPLICATION |
1 |
0.0003 |
| 248 |
TACHYPHRENIA |
1 |
0.0003 |
| 249 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 250 |
RENAL IMPAIRMENT |
24 |
0.0003 |
| 251 |
ERYTHEMA NODOSUM |
1 |
0.0003 |
| 252 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 253 |
BIPOLAR DISORDER |
3 |
0.0003 |
| 254 |
BONE LOSS |
4 |
0.0003 |
| 255 |
CHEMOTHERAPY |
1 |
0.0003 |
| 256 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 257 |
FOOT FRACTURE |
5 |
0.0003 |
| 258 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 259 |
JAUNDICE |
7 |
0.0003 |
| 260 |
NIGHTMARE |
9 |
0.0003 |
| 261 |
ANKLE FRACTURE |
4 |
0.0003 |
| 262 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 263 |
HALLUCINATION, AUDITORY |
4 |
0.0003 |
| 264 |
ANXIETY |
71 |
0.0002 |
| 265 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 266 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 267 |
RENAL FAILURE |
33 |
0.0002 |
| 268 |
HEPATITIS C |
3 |
0.0002 |
| 269 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 270 |
HYPERURICAEMIA |
1 |
0.0002 |
| 271 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 272 |
TOOTH LOSS |
5 |
0.0002 |
| 273 |
NEPHROLITHIASIS |
11 |
0.0002 |
| 274 |
PSYCHOTIC DISORDER |
7 |
0.0002 |
| 275 |
PYELONEPHRITIS |
2 |
0.0002 |
| 276 |
DYSPHEMIA |
1 |
0.0002 |
| 277 |
SPINAL OSTEOARTHRITIS |
2 |
0.0002 |
| 278 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 279 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 280 |
LOSS OF LIBIDO |
2 |
0.0002 |
| 281 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 282 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 283 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 284 |
ABNORMAL DREAMS |
6 |
0.0002 |
| 285 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 286 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 287 |
EYE DISORDER |
7 |
0.0002 |
| 288 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 289 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 290 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 291 |
TYPE 2 DIABETES MELLITUS |
7 |
0.0002 |
| 292 |
PULMONARY ARTERIAL HYPERTENSION |
3 |
0.0002 |
| 293 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 294 |
THERAPY CHANGE |
2 |
0.0002 |
| 295 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 296 |
RENAL INJURY |
6 |
0.0002 |
| 297 |
BLOOD CREATININE INCREASED |
13 |
0.0002 |
| 298 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 299 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 300 |
ENDOCARDITIS |
1 |
0.0002 |
| 301 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 302 |
MALABSORPTION |
1 |
0.0002 |
| 303 |
INCONTINENCE |
2 |
0.0002 |
| 304 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 305 |
BACK INJURY |
2 |
0.0002 |
| 306 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 307 |
NECROSIS |
1 |
0.0002 |
| 308 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 309 |
MICTURITION URGENCY |
2 |
0.0002 |
| 310 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 311 |
MYOCARDITIS |
2 |
0.0002 |
| 312 |
DYSSTASIA |
5 |
0.0002 |
| 313 |
SEXUAL DYSFUNCTION |
2 |
0.0002 |
| 314 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 315 |
ENERGY INCREASED |
1 |
0.0002 |
| 316 |
BRADYKINESIA |
1 |
0.0002 |
| 317 |
TREATMENT FAILURE |
14 |
0.0002 |
| 318 |
OESOPHAGEAL CARCINOMA |
5 |
0.0002 |
| 319 |
POLYNEUROPATHY |
2 |
0.0002 |
| 320 |
HEPATITIS B |
1 |
0.0002 |
| 321 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 322 |
OSTEOARTHRITIS |
7 |
0.0002 |
| 323 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 324 |
NOCTURIA |
2 |
0.0002 |
| 325 |
SCHIZOPHRENIA |
2 |
0.0002 |
| 326 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 327 |
CHOLANGITIS |
1 |
0.0002 |
| 328 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 329 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 330 |
LIVER DISORDER |
7 |
0.0002 |
| 331 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 332 |
NODULE |
2 |
0.0002 |
| 333 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 334 |
ABNORMAL BEHAVIOUR |
6 |
0.0002 |
| 335 |
DEPRESSED MOOD |
8 |
0.0002 |
| 336 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 337 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 338 |
APPETITE DISORDER |
1 |
0.0002 |
| 339 |
ACUTE KIDNEY INJURY |
23 |
0.0002 |
| 340 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 341 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 342 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 343 |
RIB FRACTURE |
3 |
0.0001 |
| 344 |
EXPOSURE DURING PREGNANCY |
9 |
0.0001 |
| 345 |
DEMENTIA |
4 |
0.0001 |
| 346 |
HALLUCINATION, VISUAL |
3 |
0.0001 |
| 347 |
PAPULE |
1 |
0.0001 |
| 348 |
SLEEP DISORDER |
10 |
0.0001 |
| 349 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 350 |
METASTASIS |
1 |
0.0001 |
| 351 |
IRRITABLE BOWEL SYNDROME |
3 |
0.0001 |
| 352 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 353 |
DRUG INTERACTION |
22 |
0.0001 |
| 354 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 355 |
FEELING DRUNK |
1 |
0.0001 |
| 356 |
HEPATIC FAILURE |
4 |
0.0001 |
| 357 |
HIP ARTHROPLASTY |
2 |
0.0001 |
| 358 |
LIPASE INCREASED |
1 |
0.0001 |
| 359 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 360 |
DEPRESSION |
29 |
0.0001 |
| 361 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 362 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 363 |
RENAL CYST |
1 |
0.0001 |
| 364 |
PANCYTOPENIA |
7 |
0.0001 |
| 365 |
FLATULENCE |
7 |
0.0001 |
| 366 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 367 |
OSTEONECROSIS |
4 |
0.0001 |
| 368 |
MANIA |
2 |
0.0001 |
| 369 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 370 |
POLLAKIURIA |
5 |
0.0001 |
| 371 |
ADVERSE EVENT |
11 |
0.0001 |
| 372 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 373 |
CANDIDA INFECTION |
2 |
0.0001 |
| 374 |
HYPERTENSION |
25 |
0.0001 |
| 375 |
DYSPHAGIA |
11 |
0.0001 |
| 376 |
MYOPATHY |
1 |
0.0001 |
| 377 |
PAIN |
71 |
0.0001 |
| 378 |
DIPLOPIA |
3 |
0.0001 |
| 379 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 380 |
DRUG INTOLERANCE |
11 |
0.0001 |
| 381 |
PANCREATITIS |
6 |
0.0001 |
| 382 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 383 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 384 |
THIRST |
2 |
0.0001 |
| 385 |
HAEMARTHROSIS |
1 |
0.0001 |
| 386 |
FEAR |
3 |
0.0001 |
| 387 |
SUICIDAL IDEATION |
10 |
0.0001 |
| 388 |
PRODUCT DOSE OMISSION ISSUE |
32 |
0.0001 |
| 389 |
FRACTURE |
2 |
0.0001 |
| 390 |
SPINAL DISORDER |
1 |
0.0001 |
| 391 |
GASTRIC ULCER |
2 |
0.0001 |
| 392 |
CHOLESTASIS |
2 |
0.0001 |
| 393 |
AFFECT LABILITY |
1 |
0.0001 |
| 394 |
GLAUCOMA |
2 |
0.0001 |
| 395 |
HOSPICE CARE |
1 |
0.0001 |
| 396 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 397 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 398 |
AGGRESSION |
5 |
0.0001 |
| 399 |
NO ADVERSE EVENT |
18 |
0.0001 |
| 400 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 401 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 402 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 403 |
SUICIDE ATTEMPT |
6 |
0.0001 |
| 404 |
HYPOTHERMIA |
1 |
0.0001 |
| 405 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
7 |
0.0001 |
| 406 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 407 |
TOOTH ABSCESS |
1 |
0.0001 |
| 408 |
MOBILITY DECREASED |
7 |
0.0001 |
| 409 |
SKELETAL INJURY |
1 |
0.0001 |
| 410 |
PERITONITIS |
2 |
0.0001 |
| 411 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 412 |
PETECHIAE |
1 |
0.0001 |
| 413 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 414 |
TRANSFUSION |
1 |
0.0001 |
| 415 |
AGITATION |
7 |
0.0001 |
| 416 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 417 |
RENAL PAIN |
1 |
0.0001 |
| 418 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 419 |
NIGHT SWEATS |
3 |
0.0001 |
| 420 |
HALLUCINATION |
7 |
0.0001 |
| 421 |
PRODUCT DOSE OMISSION |
6 |
0.0001 |
| 422 |
DIABETES MELLITUS |
7 |
0.0001 |
| 423 |
OESOPHAGITIS |
1 |
0.0001 |
| 424 |
IMPAIRED HEALING |
3 |
0.0001 |
| 425 |
ASPIRATION |
1 |
0.0001 |
| 426 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 427 |
TOOTH FRACTURE |
1 |
0.0001 |
| 428 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 429 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 430 |
MALNUTRITION |
1 |
0.0001 |
| 431 |
WEIGHT INCREASED |
20 |
0.0001 |
| 432 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 433 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 434 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
3 |
0.0001 |
| 435 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 436 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 437 |
VASCULITIS |
1 |
0.0001 |
| 438 |
BACTERAEMIA |
1 |
0.0001 |
| 439 |
CHOLECYSTITIS |
1 |
0.0001 |
| 440 |
WRIST FRACTURE |
1 |
0.0001 |
| 441 |
TENDON RUPTURE |
1 |
0.0001 |
| 442 |
PHARYNGITIS |
1 |
0.0001 |
| 443 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 444 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 445 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 446 |
COLITIS |
3 |
0.0001 |
| 447 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 448 |
ABDOMINAL DISTENSION |
8 |
0.0001 |
| 449 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 450 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 451 |
PRODUCT USE ISSUE |
14 |
0.0001 |
| 452 |
ANAEMIA |
14 |
0.0001 |
| 453 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 454 |
HOSPITALISATION |
11 |
0.0001 |
| 455 |
MASS |
1 |
0.0001 |
| 456 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 457 |
PAIN IN JAW |
2 |
0.0001 |
| 458 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 459 |
DIALYSIS |
1 |
0.0001 |
| 460 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 461 |
ANGINA PECTORIS |
2 |
0.0001 |
| 462 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 463 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 464 |
FLUID OVERLOAD |
1 |
0.0001 |
| 465 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 466 |
MATERNAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 467 |
PULMONARY MASS |
1 |
0.0001 |
| 468 |
INSURANCE ISSUE |
1 |
0.0001 |
| 469 |
HYPOKALAEMIA |
3 |
0.0001 |
| 470 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 471 |
LYMPHOMA |
1 |
0.0001 |
| 472 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 473 |
BRAIN FOG |
1 |
0.0001 |
| 474 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 475 |
ULCER |
1 |
0.0001 |
| 476 |
HIP FRACTURE |
2 |
0.0001 |
| 477 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 478 |
DEATH |
53 |
0.0001 |
| 479 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 480 |
VIRAL INFECTION |
2 |
0.0001 |
| 481 |
GAIT INABILITY |
2 |
0.0001 |
| 482 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 483 |
HEMIPARESIS |
1 |
0.0001 |
| 484 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 485 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 486 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 487 |
GAIT DISTURBANCE |
11 |
0.0001 |
| 488 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 489 |
NEUROTOXICITY |
1 |
0.0001 |
| 490 |
EOSINOPHILIA |
1 |
0.0001 |
| 491 |
HYPERKALAEMIA |
2 |
0.0001 |
| 492 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 493 |
DRUG ERUPTION |
1 |
0.0001 |
| 494 |
INSOMNIA |
15 |
0.0001 |
| 495 |
CONDITION AGGRAVATED |
17 |
0.0001 |
| 496 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 497 |
GOUT |
1 |
0.0001 |
| 498 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 499 |
TOOTHACHE |
1 |
0.0001 |
| 500 |
OSTEOMYELITIS |
1 |
0.0001 |
| 501 |
PELVIC PAIN |
1 |
0.0001 |
| 502 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 503 |
PANIC ATTACK |
2 |
0.0001 |
| 504 |
EYE SWELLING |
2 |
0.0001 |
| 505 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 506 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 507 |
EYE PAIN |
3 |
0.0001 |
| 508 |
PHOTOPHOBIA |
1 |
0.0001 |
| 509 |
DYSARTHRIA |
2 |
0.0001 |
| 510 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 511 |
MYALGIA |
9 |
0.0001 |
| 512 |
NAUSEA |
41 |
0.0001 |
| 513 |
ERUCTATION |
1 |
0.0001 |
| 514 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 515 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 516 |
HAEMORRHOIDS |
1 |
0.0001 |
| 517 |
ORAL HERPES |
1 |
0.0001 |
| 518 |
DISABILITY |
1 |
0.0001 |
| 519 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 520 |
DISORIENTATION |
2 |
0.0001 |
| 521 |
CARDIAC FAILURE |
4 |
0.0000 |
| 522 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 523 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 524 |
FEEDING DISORDER |
1 |
0.0000 |
| 525 |
DYSKINESIA |
2 |
0.0000 |
| 526 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 527 |
CARDIAC ARREST |
4 |
0.0000 |
| 528 |
JOINT INJURY |
1 |
0.0000 |
| 529 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 530 |
WEIGHT DECREASED |
13 |
0.0000 |
| 531 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 532 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 533 |
HEPATOTOXICITY |
1 |
0.0000 |
| 534 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 535 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 536 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 537 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 538 |
SHOCK |
1 |
0.0000 |
| 539 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 540 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 541 |
TREMOR |
7 |
0.0000 |
| 542 |
COMA |
2 |
0.0000 |
| 543 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 544 |
HEPATIC CANCER |
1 |
0.0000 |
| 545 |
LOCALISED INFECTION |
1 |
0.0000 |
| 546 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 547 |
RASH |
18 |
0.0000 |
| 548 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 549 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 550 |
ASTHENIA |
15 |
0.0000 |
| 551 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 552 |
GASTRIC CANCER |
1 |
0.0000 |
| 553 |
HAEMATEMESIS |
1 |
0.0000 |
| 554 |
THERAPY CESSATION |
2 |
0.0000 |
| 555 |
OFF LABEL USE |
34 |
0.0000 |
| 556 |
INFLAMMATION |
2 |
0.0000 |
| 557 |
HAEMATOMA |
1 |
0.0000 |
| 558 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 559 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 560 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 561 |
GASTRITIS |
1 |
0.0000 |
| 562 |
EAR INFECTION |
1 |
0.0000 |
| 563 |
DIARRHOEA |
24 |
0.0000 |
| 564 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 565 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 566 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 567 |
LIMB INJURY |
1 |
0.0000 |
| 568 |
DRUG ABUSE |
3 |
0.0000 |
| 569 |
COMPLETED SUICIDE |
3 |
0.0000 |
| 570 |
FATIGUE |
28 |
0.0000 |
| 571 |
SEPSIS |
4 |
0.0000 |
| 572 |
THROMBOCYTOPENIA |
4 |
0.0000 |
| 573 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 574 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 575 |
HYPERSOMNIA |
1 |
0.0000 |
| 576 |
LETHARGY |
2 |
0.0000 |
| 577 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 578 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 579 |
DECREASED APPETITE |
8 |
0.0000 |
| 580 |
BONE PAIN |
2 |
0.0000 |
| 581 |
ASCITES |
1 |
0.0000 |
| 582 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 583 |
CATARACT |
2 |
0.0000 |
| 584 |
APHASIA |
1 |
0.0000 |
| 585 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 586 |
FEMUR FRACTURE |
1 |
0.0000 |
| 587 |
CONSTIPATION |
7 |
0.0000 |
| 588 |
MOOD SWINGS |
1 |
0.0000 |
| 589 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 590 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 591 |
PNEUMONIA |
10 |
0.0000 |
| 592 |
SWELLING FACE |
2 |
0.0000 |
| 593 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 594 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 595 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 596 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 597 |
LIP SWELLING |
1 |
0.0000 |
| 598 |
HAEMATURIA |
1 |
0.0000 |
| 599 |
ILLNESS |
3 |
0.0000 |
| 600 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 601 |
DRUG INEFFECTIVE |
38 |
0.0000 |
| 602 |
DELIRIUM |
1 |
0.0000 |
| 603 |
RASH MACULAR |
1 |
0.0000 |
| 604 |
HEART RATE DECREASED |
1 |
0.0000 |
| 605 |
HYPOXIA |
1 |
0.0000 |
| 606 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 607 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 608 |
RESTLESSNESS |
1 |
0.0000 |
| 609 |
HEADACHE |
17 |
0.0000 |
| 610 |
INJECTION SITE MASS |
1 |
0.0000 |
| 611 |
FALL |
9 |
0.0000 |
| 612 |
INFLUENZA |
3 |
0.0000 |
| 613 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 614 |
HYPOAESTHESIA |
4 |
0.0000 |
| 615 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 616 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 617 |
DIZZINESS |
13 |
0.0000 |
| 618 |
SEIZURE |
3 |
0.0000 |
| 619 |
BACK PAIN |
6 |
0.0000 |
| 620 |
FEELING ABNORMAL |
6 |
0.0000 |
| 621 |
DRY MOUTH |
2 |
0.0000 |
| 622 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 623 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 624 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 625 |
PRURITUS |
9 |
0.0000 |
| 626 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 627 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 628 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 629 |
ANGIOEDEMA |
1 |
0.0000 |
| 630 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 631 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 632 |
TINNITUS |
1 |
0.0000 |
| 633 |
CHEST PAIN |
4 |
0.0000 |
| 634 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 635 |
ARRHYTHMIA |
1 |
0.0000 |
| 636 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 637 |
MIGRAINE |
2 |
0.0000 |
| 638 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 639 |
CONTUSION |
2 |
0.0000 |
| 640 |
DYSPEPSIA |
2 |
0.0000 |
| 641 |
PYREXIA |
7 |
0.0000 |
| 642 |
CELLULITIS |
1 |
0.0000 |
| 643 |
ERYTHEMA |
4 |
0.0000 |
| 644 |
ARTHRALGIA |
8 |
0.0000 |
| 645 |
HAEMORRHAGE |
2 |
0.0000 |
| 646 |
ECZEMA |
1 |
0.0000 |
| 647 |
PARAESTHESIA |
3 |
0.0000 |
| 648 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 649 |
RASH PRURITIC |
1 |
0.0000 |
| 650 |
DEPENDENCE |
1 |
0.0000 |
| 651 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 652 |
URTICARIA |
3 |
0.0000 |
| 653 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 654 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 655 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 656 |
PALPITATIONS |
2 |
0.0000 |
| 657 |
SURGERY |
1 |
0.0000 |
| 658 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 659 |
IRRITABILITY |
1 |
0.0000 |
| 660 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 661 |
STOMATITIS |
1 |
0.0000 |
| 662 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 663 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 664 |
VERTIGO |
1 |
0.0000 |
| 665 |
FEELING HOT |
1 |
0.0000 |
| 666 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 667 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 668 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 669 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 670 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 671 |
ALOPECIA |
3 |
0.0000 |
| 672 |
SOMNOLENCE |
3 |
0.0000 |
| 673 |
VOMITING |
7 |
0.0000 |
| 674 |
VISION BLURRED |
2 |
0.0000 |
| 675 |
INJURY |
1 |
0.0000 |
| 676 |
DYSPNOEA |
8 |
0.0000 |
| 677 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 678 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 679 |
DYSGEUSIA |
1 |
0.0000 |
| 680 |
HOT FLUSH |
1 |
0.0000 |
| 681 |
ACNE |
1 |
0.0000 |
| 682 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 683 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 684 |
PROSTATE CANCER |
1 |
0.0000 |
| 685 |
THROMBOSIS |
1 |
0.0000 |
| 686 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 687 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 688 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 689 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 690 |
COVID-19 |
2 |
0.0000 |
| 691 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 692 |
TACHYCARDIA |
1 |
0.0000 |
| 693 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 694 |
MUSCLE SPASMS |
2 |
0.0000 |
| 695 |
CARDIAC DISORDER |
1 |
0.0000 |
| 696 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 697 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 698 |
SYNCOPE |
1 |
0.0000 |
| 699 |
FLUSHING |
1 |
0.0000 |
| 700 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 701 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 702 |
OVERDOSE |
2 |
0.0000 |
| 703 |
MALAISE |
4 |
0.0000 |
| 704 |
ASTHMA |
1 |
0.0000 |
| 705 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 706 |
HYPERHIDROSIS |
1 |
0.0000 |
| 707 |
DRY SKIN |
1 |
0.0000 |
| 708 |
COUGH |
2 |
0.0000 |
| 709 |
INFECTION |
1 |
0.0000 |
| 710 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 711 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 712 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |